MedTrace Logo

Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL)

NCT00747227 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2011-11-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and effectiveness of a new investigational modified light transmission monofocal intraocular lens compared to a conventional intraocular lens (IOL).

Conditions

  • Cataract

Interventions

DEVICE

modified light transmission intraocular lens

violet visible light blocking acrylic intraocular lens

DEVICE

monofocal acrylic intraocular lens

conventional hydrophobic acrylic intraocular lens

Sponsors & Collaborators

  • Abbott Medical Optics

    lead INDUSTRY

Principal Investigators

  • Roger F. Steinert, M.D. · University of California, Irvine, Dept. of Ophthalmology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2009-03-31
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00747227 on ClinicalTrials.gov